Episode Details
Back to Episodes
Episode 479: Does the Timing of IO Infusion Impact Clinical Outcomes? A Critical Analysis
Published 8 months ago
Description
This episode critically examines a recent Nature Medicine paper on the timing of immune therapy infusion in lung cancer, exploring the scientific plausibility, methodological concerns, and implications for future research. Tom, Brian and David McDermott debate the validity of the findings, the review process, and the need for rigorous prospective trials.